Last Updated: November 9, 2026

Details for Patent: 11,795,204

Name: Drug Patent Intelligence for US Patent 11795204
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which drugs does patent 11,795,204 protect, and when does it expire?

Patent 11,795,204 protects ZEGALOGUE and ZEGALOGUE (AUTOINJECTOR) and is included in one NDA.

This patent has thirty-six patent family members in twenty-seven countries.

Summary for Patent: 11,795,204

Title:	Glucagon analogues
Abstract:	The present invention relates to glucagon analogues and their medical use, for example in the treatment of hypoglycaemia. In particular, the present invention relates to stable glucagon analogues suitable for use in a liquid formulation.
Inventor(s):	Ditte Riber, Lise Giehm
Assignee:	Zealand Pharma AS
Application Number:	US16/566,992
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 11,795,204

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Zealand Pharma	ZEGALOGUE	dasiglucagon hydrochloride	SOLUTION;SUBCUTANEOUS	214231-001	Mar 22, 2021		DISCN	Yes	No	11,795,204	⤷ Start Trial				METHOD OF TREATING DIABETIC HYPOGLYCEMIA	⤷ Start Trial
Zealand Pharma	ZEGALOGUE (AUTOINJECTOR)	dasiglucagon hydrochloride	SOLUTION;SUBCUTANEOUS	214231-002	Mar 22, 2021		DISCN	Yes	No	11,795,204	⤷ Start Trial				METHOD OF TREATING DIABETIC HYPOGLYCEMIA	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 11,795,204

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2875043	⤷ Start Trial	301294	Netherlands	⤷ Start Trial
European Patent Office	2875043	⤷ Start Trial	CR 2024 00043	Denmark	⤷ Start Trial
European Patent Office	2875043	⤷ Start Trial	122024000057	Germany	⤷ Start Trial
European Patent Office	2875043	⤷ Start Trial	C20240034	Finland	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.